SCHEMBL3605553

SCHEMBL3605553

Cc1cc(CNc2ccc(Cl)cc2)cc(C)c1NC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.52
MAPT P10636 1/20 0.50
HDAC1 Q13547 1/20 0.49
CNR1 P21554 1/20 0.46
PPARA Q07869 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.45
SCD O00767 1/20 0.45
RAB9A P51151 3/20 0.45
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
RECQL P46063 1/20 0.45
KMT2A Q03164 1/20 0.45
NPC1 O15118 2/20 0.44
HIF1A Q16665 3/20 0.44
TP53 P04637 1/20 0.43
CNR2 P34972 1/20 0.43
HDAC4 P56524 1/20 0.43
MEF2D Q14814 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3095185 0.86 MAPT (0.55) FFAR1MAPTHDAC1SCDRAB9A
SCHEMBL3609796 0.85 P4HTM (0.50) FFAR1MAPTPPARARAB9ANPC1
SCHEMBL30795764 0.83 HPGD (0.55) FFAR1MAPTSCDMEN1CYP1A2
SCHEMBL3591356 0.82 HIF1A (0.59) FFAR1MAPTHDAC1RAB9AMEN1
SCHEMBL3106692 0.82 MAPT (0.51) FFAR1MAPTHDAC1PPARARAB9A
SCHEMBL3247396 0.81 FFAR1 (0.56) FFAR1MAPTPPARAPTGDR2RAB9A
SCHEMBL3101950 0.81 MAPT (0.49) FFAR1MAPTHDAC1CNR1PPARA
SCHEMBL3106451 0.80 RAB9A (0.52) RAB9AMEN1CYP1A2CYP2C19KMT2A
SCHEMBL3101955 0.78 RAB9A (0.50) FFAR1MAPTHDAC1RAB9AMEN1
SCHEMBL3613056 0.75 MEN1 (0.49) FFAR1MAPTPPARARAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100063044-A1 SUBSTITUTED ANILINE DERIVATIVES H. LUNDBECK A/S (DK) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063044-A1 SUBSTITUTED ANILINE DERIVATIVES NDUFS3, NAT1, PRMT3 FFAR1 1653/4885MAPT 2817/4885HDAC1 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.